MetaCure Implant For Type 2 Diabetes: Overseas Trials To Wrap Up By 2012
This article was originally published in The Gray Sheet
Executive Summary
MetaCure plans to wrap up three overseas trials by the end of 2012 for its DIAMOND electrostimulator implant for type 2 diabetes in obese patients and will begin a pivotal U.S. trial within the next couple of years to support a PMA submission for type 2 diabetes.